Genetic and plasma markers of venous thromboembolism in patients with high grade glioma.
D001932:Brain Neoplasms / Q000097:blood / Q000150:complications / Q000235:genetics; D016022:Case-Control Studies; D005338:Fibrin Fibrinogen Degradation Products / Q000235:genetics; D017353:Gene Deletion; D005838:Genotype; D005910:Glioma / Q000097:blood* / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D006710:Homocysteine / Q000235:genetics; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D009103:Multiple Sclerosis / Q000097:blood; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics; D011110:Polymorphism, Genetic; D011379:Prognosis; D012307:Risk Factors; D013923:Thromboembolism / Q000097:blood* / Q000175:diagnosis / Q000235:genetics*; D010959:Tissue Plasminogen Activator / Q000235:genetics; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics
D005338:Fibrin Fibrinogen Degradation Products; D008074:Lipoproteins; D017395:Plasminogen Activator Inhibitor 1; D042461:Vascular Endothelial Growth Factor A; C036309:fibrin fragment D; D006710:Homocysteine; D010959:Tissue Plasminogen Activator